Research
- Research Topics
- Cell Biology and Tumor Biology
- Stem Cells and Cancer
- Inflammatory Stress in Stem Cells
- Experimental Hematology
- Molecular Embryology
- Signal Transduction and Growth Control
- Epigenetics
- Redox Regulation
- Vascular Oncology and Metastasis
- Clinical Neurobiology
- Molecular Neurogenetics
- Chaperones and Proteases
- Vascular Signaling and Cancer
- Molecular Neurobiology
- Mechanisms Regulating Gene Expression
- Molecular Biology of Centrosomes and Cilia
- Dermato-Oncology
- Molecular Hematology - Oncology
- Metastatic Niches
- Molecular Leukemogenesis
- DNA Repair Mechanisms and Cancer
- Neuronal Signaling and Morphogenesis
- Cell Signaling and Metabolism
- Cell Fate Engineering and Disease Modeling
- Cancer Drug Development
- Cell Morphogenesis and Signal Transduction
- Tumour Metabolism and Microenvironment
- Helmholtz Professorship Cell Biology
- Functional and Structural Genomics
- Cancer Epigenomics
- Molecular Genome Analysis
- Applied Functional Genomics
- Molecular Genetics
- Pediatric Neurooncology
- Applied Bioinformatics
- Translational Medical Oncology
- Cancer Genome Research
- Chromatin Networks
- Functional Genome Analysis
- Theoretical Systems Biology
- Neuroblastoma Genomics
- Signaling and Functional Genomics
- Signal Transduction in Cancer and Metabolism
- Brain Cancer Metabolism
- Neurooncology
- Pediatric Oncology
- RNA Biology and Cancer
- Systems Biology of Signal Transduction
- Neuropathology
- Molecular thoracic Oncology
- Proteomics of Stem Cells and Cancer
- Computational Genomics and System Genetics
- Regulatory Genomics and Cancer Evolution
- Pediatric Glioma Research
- Soft-Tissue Sarcoma
- Precision Sarcoma Research
- Neural Stem Cell Genome Integrity in Brain Development and Diseases
- Somatic Evolution and Early Detection
- Bioinformatics and Omics Data Analytics
- Translational Control and Metabolism
- Mechanisms of Leukemogenesis
- Genome Instability in Tumors
- Brain Tumor Translational Targets
- Molecular Genetics of Breast Cancer
- Translational Functional Cancer Genomics
- Cancer Risk Factors and Prevention
- Cancer Epidemiology
- Preventive Oncology
- Clinical Epidemiology and Aging Research
- Physical Activity, Prevention and Cancer
- Biostatistics
- Genomic Epidemiology
- Cancer Survivorship
- Health Economics
- Molecular Epidemiology
- Immunology and Cancer
- Immunogenetics
- Cellular Immunology
- Molecular Oncology of Gastrointestinal Tumors
- Translational Immunotherapy
- B Cell Immunology
- Immune Diversity
- Structural Biology of Infection and Immunity
- Applied Tumor-Immunity
- Neuroimmunology and Brain Tumor Immunology
- T Cell Metabolism
- Adaptive Immunity and Lymphoma
- Immune Regulation in Cancer
- GMP & T Cell Therapy
- News
- Imaging and Radiooncology
- Radiology
- Research
- Computational Radiology Research Group
- Contrast Agents In Radiology Research Group
- Neuro-Oncologic Imaging Research Group
- Radiological Early Response Assessment Of Modern Cancer Therapies
- Imaging In Monoclonal Plasma Cell Disorders
- 7 Tesla MRI - Novel Imaging Biomarkers
- Functional Imaging
- Visualization And Forensic Imaging
- PET/MRI
- Dual- and Multienergy CT
- Radiomics Research Group
- Prostate Research Group
- Breast Imaging Research Group
- Bone marrow
- Musculoskeletal Imaging
- Staff
- Patients
- Research
- Medical Physics in Radiology
- X-Ray Imaging and Computed Tomography
- Medical Informatics for Translational Oncology
- Federated Information Systems
- Radiopharmaceutical Chemistry
- Medical Physics in Radiation Oncology
- Faculty & Staff
- Research
- Computational Patient Models
- Applied Medical Radiation Physics
- Therapy Planning - Development
- Current Projects
- Former Projects
- Adaptive Radiotherapy
- Registration
- Functional Imaging
- Knowledge based radiotherapy planning (TAPIR)
- New technologies for transferring therapeutical knowledge (IRIS)
- Planning System for proton therapy of eye tumors (OCTOPUS)
- Image Processing and Represenation (VIS-A-VIS)
- Stereotactic laser neurosurgery (STELA)
- Contact
- Research Interest
- Radiotherapy Optimization
- Medical Engineering
- Novel Detection Techniques for Ion Beams
- Physical Quality Assurance in Radiation Therapy
- Ion Beam Therapy
- MR-guided RadioTherapy
- Clinical Research Group
- Publications
- Awards
- CGCoMPRO
- DKFZ PhD Program & Vacancies
- Education and Training
- Events
- Biomedical Physics in Radiation Oncology
- Computer Assisted Medical Interventions
- Medical Image Computing
- Radiooncology - Radiobiology
- Radiation Oncology
- Molecular Radiooncology
- Nuclear Medicine
- Medical Imaging and Radiology - Cancer Prevention
- Molecular Biology of Systemic Radiotherapy
- Translational Radiation Oncology
- Molecular Mechanisms of Head and Neck Tumors
- Radiology
- Infection, Inflammation and Cancer
- Tumor Virology
- Viral Transformation Mechanisms
- Pathogenesis of Virus-Associated Tumors
- Applied Tumor Biology
- Virotherapy
- Virus-associated Carcinogenesis
- Chronic Inflammation and Cancer
- Microbiome and Cancer
- Cell Plasticity and Epigenetic Remodeling
- Cellular Polarity and Viral Infection
- Noroviruses
- Laboratory of Oncolytic Virus Immuno-Therapeutics
- Infections and Cancer Epidemiology
- Tumorvirus-specific Vaccination Strategies
- Mammalian Cell Cycle Control Mechanisms
- Molecular Therapy of Virus-Associated Cancers
- Immunotherapy and Immunoprevention - Molecular Vaccine Design
- DNA Vectors
- Episomal-Persistent DNA in Cancer- and Chronic Diseases
- Other Units
- Cell Biology and Tumor Biology
- Research Groups A-Z
- Junior Research Groups
- Core Facilities
- Center for Preclinical Research
- Chemical Biology Core Facility
- Electron Microscopy
- Flow Cytometry
- Genomics and Proteomics
- Information Technology
- Library
- Kataloge - Catalogues
- Zeitschriften - Journals
- E-Books - Ebooks
- Datenbanken - Databases
- Dokument-Lieferung - Document Delivery
- Publikationsdatenbank - Publication database
- DKFZ Archiv - DKFZ Archive
- Open Access
- Science 2.0
- Ansprechpartner - Contact
- More Information - Service
- Anschrift - Address
- Antiquariat - Second Hand
- Aufstellungssystematik - Shelf Classification
- Ausleihe - Circulation
- Benutzerhinweise - Library Use
- Beschaffungsvorschläge - Desiderata
- Fakten und Zahlen - Facts and Numbers
- Kooperationen, Konsortien - Cooperations, Consortia
- Kopieren, Scannen - Copying, Scans
- Kurse, Führungen - Courses, Introductions
- Öffnungszeiten - Opening Hours
- DEAL-Info
- DKFZ-Intern - internal only
- Light Microscopy
- Omics IT and Data Management Core Facility
- Small Animal Imaging
- Data Science @ DKFZ
- INFORM
- Databox
- Baden-Württemberg Cancer Registry
- Cooperations & Networks
- National Cooperations
- International Cooperations
- Cooperational Research Program with Israel: DKFZ - MOST in Cancer Research
- Program
- Members of the Program Committee
- Call 2019
- Publication Database
- German-Israeli Cancer Research Schools
- Archive
- Heidelberg - Israel, Science and Culture
- Symposium 40 Years of German-Israeli Cooperation
- 35th Anniversary Symposium
- 34th Meeting of the DKFZ-MOST Program
- 40th Anniversary Publication
- 30th Anniversary Publication
- 20th Anniversary Publication
- Flyer - The Cancer Cooperation Program
- List Publications 1976-2004
- Highlight-Projects
- Cooperational Research Program with Israel: DKFZ - MOST in Cancer Research
- Cooperations with industrial companies
- Helmholtz Alliances
- DKFZ PostDoc Network
- Cross Program Topic RNA@DKFZ
- Cross Program Topic Epigenetics@dkfz
- Cross Program Topic Single Cell Sequencing
- iMed
- WHO Collaborating Centers
Division of Applied Functional Genomics
Prof. Dr. Claudia Scholl
All human cancers are characterized by the acquisition of mutations, such as single-nucleotide variants, small insertions/deletions or copy number alterations. While many of these lesions have been associated with biological characteristics of tumors, the contribution of most mutations to cancer development is unclear. In addition, somatically acquired genetic alterations result in complex quantitative and qualitative changes of intracellular signaling networks during malignant transformation, thereby inducing specific dependencies on genes that are not directly affected by mutations. The mission of our laboratory is to find and characterize such specific vulnerabilities in cancer cells that can be exploited for the development of targeted therapies. To achieve this goal, we use a broad spectrum of molecular and cell biological technologies, such as RNA interference or CRISPR/Cas9-mediated genome editing on small and large scale in combination with the analysis of diverse in vitro and in vivo phenotypic readouts.
We are particularly focusing on the identification and characterization of genotype-selective functional vulnerabilities in acute myeloid leukemia (AML) and solid-organ malignancies harboring oncogenic KRAS mutations. In addition, we are using lung tumor mouse models and proteomic approaches to delineate the function of STK33, an uncharacterized serine/threonine kinase that is essential for the survival of mutant KRAS-dependent cancer cells. We also developed genetically engineered mouse models for the Identification of normal and malignant lung epithelial stem cells and delineation of regulatory pathways within these cell types through single-cell RNA sequencing. Finally, we recently initiated a collaborative scientific program centered on the systematic functional characterization of rare mutations in cancer genomes, complementing translationally oriented cancer genome sequencing efforts. This approach will allow the systematic discrimination between pathogenetically relevant driver mutations and biologically neutral passenger alterations.
FUTURE OUTLOOK
We will continue to work towards a better understanding of specific functional dependencies in AML and, in particular, KRAS mutant cancers. The identification of new lung stem and progenitor cell types will allow us to investigate their role in mutant KRAS-induced lung tumor formation using newly generated mouse models. Finally, we aim to systematically and comprehensively map the function of rare and uncharacterized cancer mutations, which will provide novel mechanistic insights into key cellular pathways and help guide the translation of genomic information into clinical application.